User profiles for Nicole E Stoesser
 | Nicole StoesserVerified email at ndm.ox.ac.uk Cited by 14340 |
[HTML][HTML] Antibody status and incidence of SARS-CoV-2 infection in health care workers
SF Lumley, D O'Donnell, NE Stoesser… - … England Journal of …, 2021 - Mass Medical Soc
Background The relationship between the presence of antibodies to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains …
syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains …
Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
…, R Esposito, TJ Louie, NE Stoesser… - Clinical Infectious …, 2012 - academic.oup.com
Two recently completed phase 3 trials (003 and 004) showed fidaxomicin to be noninferior
to vancomycin for curing Clostridium difficile infection (CDI) and superior for reducing CDI …
to vancomycin for curing Clostridium difficile infection (CDI) and superior for reducing CDI …
The duration, dynamics, and determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody responses in individual healthcare workers
…, J Wei, D O'Donnell, NE Stoesser… - Clinical Infectious …, 2021 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin
G (IgG) antibody measurements can be used to estimate the proportion of a population …
G (IgG) antibody measurements can be used to estimate the proportion of a population …
The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers
Background SARS-CoV-2 IgG antibody measurements can be used to estimate the
proportion of a population exposed or infected and may be informative about the risk of future …
proportion of a population exposed or infected and may be informative about the risk of future …
[HTML][HTML] Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status
…, DW Crook, TEA Peto, TM Walker, NE Stoesser… - Clinical Microbiology …, 2021 - Elsevier
Objectives We investigated determinants of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) anti-spike IgG responses in healthcare workers (HCWs) following one or …
2 (SARS-CoV-2) anti-spike IgG responses in healthcare workers (HCWs) following one or …
[HTML][HTML] Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small …
…, AM O'Donnell, TM Walker, NE Stoesser… - Journal of Infection, 2021 - Elsevier
Objectives: Despite robust efforts, patients and staff acquire SARS-CoV-2 infection in
hospitals. We investigated whether whole-genome sequencing enhanced the epidemiological …
hospitals. We investigated whether whole-genome sequencing enhanced the epidemiological …
[HTML][HTML] Changes in paediatric respiratory infections at a UK teaching hospital 2016–2021; impact of the SARS-CoV-2 pandemic
…, DW Eyre, DW Crook, S Beer, A Novak, NE Stoesser… - Journal of Infection, 2022 - Elsevier
Objective To describe the impact of the SARS-CoV-2 pandemic on the incidence of paediatric
viral respiratory tract infection in Oxfordshire, UK. Methods Data on paediatric Emergency …
viral respiratory tract infection in Oxfordshire, UK. Methods Data on paediatric Emergency …
An observational cohort study on the incidence of SARS-CoV-2 infection and B. 1.1. 7 variant infection in healthcare workers by antibody and vaccination status
Background Natural and vaccine-induced immunity will play a key role in controlling the
SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-…
SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-…
Antibodies to SARS-CoV-2 are associated with protection against reinfection
Background It is critical to understand whether infection with Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) protects from subsequent reinfection. Methods We …
Syndrome Coronavirus 2 (SARS-CoV-2) protects from subsequent reinfection. Methods We …
An observational cohort study on the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and B. 1.1. 7 variant infection in …
Background Natural and vaccine-induced immunity will play a key role in controlling the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. SARS-CoV-2 …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. SARS-CoV-2 …
